Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Otorhinolaryngology

  Free Subscription


Articles published in Head Neck

Retrieve available abstracts of 336 articles:
HTML format



Single Articles


    July 2022
  1. WADHAVKAR N, Jorgensen JB, Bollig CA
    Association of comorbidity score with perioperative outcomes following transoral robotic surgery: National analysis.
    Head Neck. 2022;44:1655-1664.
    PubMed     Abstract available


  2. FROEHLICH MH, Shih MC, Shehee L, Kompelli AR, et al
    Systematic review of neuroendocrine carcinomas of the oropharynx.
    Head Neck. 2022;44:1725-1736.
    PubMed     Abstract available


  3. SWIECICKI PL, Bellile E, Casper K, Chinn SB, et al
    Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor.
    Head Neck. 2022;44:1509-1519.
    PubMed     Abstract available


  4. SEO GT, Wein LE, Dowling EM, Khorsandi AS, et al
    A novel technique for management of stenosis of the postlaryngectomy stoma with preservation of a functional tracheoesophageal puncture following tracheal resection.
    Head Neck. 2022;44:1737-1741.
    PubMed     Abstract available


    June 2022
  5. HO CM, Chen YH, Hsu WH, Wang WY, et al
    Comparative effectiveness and stage-shift effect of endoscopic exam among newly diagnosed oral cancer patients with different stages in Taiwan.
    Head Neck. 2022 Jun 25. doi: 10.1002/hed.27123.
    PubMed     Abstract available


  6. AL-QURAYSHI Z, Sullivan CB, Allison DB, Buchakjian MR, et al
    Presentation and outcomes of patients with clinically T1-2, N0 parotid mucoepidermoid carcinoma: The roles of elective neck dissection and adjuvant radiotherapy.
    Head Neck. 2022 Jun 22. doi: 10.1002/hed.27128.
    PubMed     Abstract available


  7. DAI Y, Wang Z, Yan E, Li J, et al
    Development of a novel signature derived from single cell RNA-sequencing for preoperative prediction of lymph node metastasis in head and neck squamous cell carcinoma.
    Head Neck. 2022 Jun 21. doi: 10.1002/hed.27126.
    PubMed     Abstract available


  8. SHAO YF, Kim S, Cramer JD, Farhat D, et al
    African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27107.
    PubMed     Abstract available


  9. COSTANTINO A, Canali L, Festa BM, Spriano G, et al
    Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma of the head and neck: Systematic review and meta-analysis.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27121.
    PubMed     Abstract available


  10. DENISSOFF A, Huusko T, Ventela S, Niemela S, et al
    Exposure to alcohol and overall survival in head and neck cancer: A regional cohort study.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27125.
    PubMed     Abstract available


  11. YANG A, Tanamal P, Tibbetts K, Sumer B, et al
    Characteristics and outcomes of young patients with laryngeal cancer: National hospital-based retrospective cohort analysis.
    Head Neck. 2022 Jun 16. doi: 10.1002/hed.27120.
    PubMed     Abstract available


  12. SCHAR MS, Omari TI, Woods CM, Footner LR, et al
    Pharyngeal tongue base augmentation for dysphagia therapy: A prospective case series in patients post head and neck cancer treatment.
    Head Neck. 2022 Jun 4. doi: 10.1002/hed.27104.
    PubMed     Abstract available


  13. CHARGI N, Breik O, Forouzanfar T, Martin T, et al
    Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with head and neck cancer.
    Head Neck. 2022 Jun 2. doi: 10.1002/hed.27113.
    PubMed     Abstract available


  14. MAZZONI A, Cazzador D, Marioni G, Zanoletti E, et al
    Treatment of advanced squamous cell carcinoma of the external auditory canal: Critical analysis of persistent failures in diagnosis and surgery with a competing-risk model.
    Head Neck. 2022 Jun 2. doi: 10.1002/hed.27111.
    PubMed     Abstract available


  15. ABU-SHAMA Y, Renard S, Nguyen DT, Henrot P, et al
    Descriptive analysis of recurrences of nasal intestinal-type adenocarcinomas after radiotherapy.
    Head Neck. 2022;44:1356-1367.
    PubMed     Abstract available


  16. DIERCKS GR, Rastatter JC, Kazahaya K, Kamani D, et al
    Pediatric intraoperative nerve monitoring during thyroid surgery: A review from the American Head and Neck Society Endocrine Surgery Section and the International Neural Monitoring Study Group.
    Head Neck. 2022;44:1468-1480.
    PubMed     Abstract available


  17. DE RAVIN E, Frost AS, Mady LJ, Newman JG, et al
    Transcervical styloidectomy for Eagle syndrome.
    Head Neck. 2022;44:1492-1495.
    PubMed     Abstract available


  18. TSANG RK, Chan WCP, Holsinger FC, Chung JCK, et al
    Long-term results of robotic-assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Jun 1. doi: 10.1002/hed.27115.
    PubMed     Abstract available


    May 2022
  19. KOKSAL M, Saur L, Scafa D, Sarria G, et al
    Late toxicity-related symptoms and fraction dose affect decision regret among patients receiving adjuvant radiotherapy for head and neck cancer.
    Head Neck. 2022 May 30. doi: 10.1002/hed.27103.
    PubMed     Abstract available


  20. NABUURS CH, Kievit W, Leemans CR, Smit CFGM, et al
    Evaluation of subclasses for T4-classified squamous cell carcinoma of the external auditory canal.
    Head Neck. 2022 May 13. doi: 10.1002/hed.27082.
    PubMed     Abstract available


  21. LEE J, Lee JJB, Cha IH, Park KR, et al
    Risk factor analysis of dental implants in patients with irradiated head and neck cancer.
    Head Neck. 2022 May 12. doi: 10.1002/hed.27080.
    PubMed     Abstract available


  22. DESHMUKH J, Chatterjee A, Dora TK, Bose S, et al
    Recurrence pattern with respect to two different dose fractionations in patients with locally advanced head and neck cancer treated with chemoradiation using image-guided volumetric arc therapy.
    Head Neck. 2022 May 10. doi: 10.1002/hed.27075.
    PubMed     Abstract available


  23. KUTUK T, McAllister NC, Rzepczynski AE, Williams A, et al
    Submandibular gland transfer for the prevention of radiation-induced xerostomia in oropharyngeal cancer: Dosimetric impact in the intensity modulated radiotherapy era.
    Head Neck. 2022;44:1213-1222.
    PubMed     Abstract available


  24. PETRELLI F, Luciani A, Ghidini A, Cherri S, et al
    Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis.
    Head Neck. 2022;44:1255-1266.
    PubMed     Abstract available


  25. MULLER RG, Weidenbecher M, Ludlow D
    PET/CT versus triple endoscopy in initial workup of HPV+ oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1164-1171.
    PubMed     Abstract available


  26. STEPAN K, Craig E, Skillington SA, Deutsch BC, et al
    Development of second primary malignancies after transoral surgery in human papilloma virus-positive oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1069-1078.
    PubMed     Abstract available


  27. STEVENS MN, Gallant JN, Feldman MJ, Sermarini AJ, et al
    Management of postradiation late hemorrhage following treatment for HPV-positive oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1079-1085.
    PubMed     Abstract available


    April 2022
  28. FORMAN R, Deshpande H, Burtness B, Bhatia AK, et al
    Efficacy and toxicity of weekly paclitaxel, carboplatin, and cetuximab as induction chemotherapy or in cases of metastases or relapse for head and neck cancer with a focus on elderly or frail patients.
    Head Neck. 2022 Apr 30. doi: 10.1002/hed.27077.
    PubMed     Abstract available


  29. KOBAYASHI K, Ikeda A, Matsumoto Y, Matsumura S, et al
    Surgical technique for superselective neck dissection under local anesthesia in recurrent head and neck cancer.
    Head Neck. 2022 Apr 26. doi: 10.1002/hed.27071.
    PubMed     Abstract available


  30. LI D, Li X, Fan G, Bian G, et al
    Identification of the regulatory role of the circ_0004788/miR-515-5p/FGF2 network in nasopharyngeal carcinoma development.
    Head Neck. 2022 Apr 23. doi: 10.1002/hed.27066.
    PubMed     Abstract available


  31. EARNEST-NOBLE LB, Lipsky RS, Kuhel WI, Kutler DI, et al
    Identification of occult metastatic disease via lymphoscintigraphy-guided neck dissection in N0 oral squamous cell carcinoma.
    Head Neck. 2022 Apr 16. doi: 10.1002/hed.27059.
    PubMed     Abstract available


  32. MUKHERJEE A, Wiener HW, Griffin RL, Lenneman C, et al
    Racial and rural-urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort.
    Head Neck. 2022 Apr 9. doi: 10.1002/hed.27054.
    PubMed     Abstract available


  33. ZHANG W, Li L, Guo E, Zhou H, et al
    Inhibition of PDK1 enhances radiosensitivity and reverses epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Head Neck. 2022 Apr 8. doi: 10.1002/hed.27053.
    PubMed     Abstract available


  34. KORPICS MC, Turchan WT, Koshy M, Spiotto MT, et al
    Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis.
    Head Neck. 2022 Apr 7. doi: 10.1002/hed.27050.
    PubMed     Abstract available


  35. MAO M, Qiu K, Ren J, Zhao Y, et al
    The revised Pittsburgh staging system for middle ear squamous cell carcinoma: A challenging clinical dilemma.
    Head Neck. 2022 Apr 5. doi: 10.1002/hed.27047.
    PubMed    


  36. JIN YN, Liu BQ, Peng KW, Ou XQ, et al
    The prognostic value of adding systemic inflammation response index to Epstein-Barr virus DNA in childhood nasopharyngeal carcinoma: A real-world study.
    Head Neck. 2022 Apr 4. doi: 10.1002/hed.27033.
    PubMed     Abstract available


  37. BIRKENBEUEL JL, Pang JC, Lee A, Nguyen ES, et al
    Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review.
    Head Neck. 2022;44:1014-1029.
    PubMed     Abstract available


  38. LEE HI, Kim JH, Lee JH, Wu HG, et al
    Reducing target volume in definitive radiotherapy for human papillomavirus-associated tonsil cancer.
    Head Neck. 2022;44:989-997.
    PubMed     Abstract available


  39. AGGARWAL P, Hutcheson KA, Goepfert RP, Garden AS, et al
    Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors.
    Head Neck. 2022;44:952-963.
    PubMed     Abstract available


  40. ADILBAY D, Valero C, Fitzgerald C, Yuan A, et al
    Outcomes in surgical management of sinonasal malignancy-A single comprehensive cancer center experience.
    Head Neck. 2022;44:933-942.
    PubMed     Abstract available


  41. YANG B, Eliot M, McClean MD, Waterboer T, et al
    DNA methylation-derived systemic inflammation indices and their association with oropharyngeal cancer risk and survival.
    Head Neck. 2022;44:904-913.
    PubMed     Abstract available


  42. WU SS, Chen B, Fleming CW, Shah AA, et al
    Nasopharyngeal cancer: Incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution.
    Head Neck. 2022;44:851-861.
    PubMed     Abstract available


  43. BOLLIG CA, Morris B, Stubbs VC
    Transoral robotic surgery with neck dissection versus nonsurgical treatment in stage I and II human papillomavirus-negative oropharyngeal cancer.
    Head Neck. 2022 Apr 1. doi: 10.1002/hed.27045.
    PubMed     Abstract available


  44. TWU CW, Lin PJ, Tsou HH, Liu YC, et al
    Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Apr 1. doi: 10.1002/hed.27044.
    PubMed     Abstract available


    March 2022
  45. ARBAB M, Chen YH, Tishler RB, Gunasti L, et al
    Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers.
    Head Neck. 2022 Mar 31. doi: 10.1002/hed.27031.
    PubMed     Abstract available


  46. GETZ KR, Bellile E, Zarins KR, Chinn SB, et al
    The association between inflammatory biomarkers and statin use among patients with head and neck squamous cell carcinoma.
    Head Neck. 2022 Mar 25. doi: 10.1002/hed.27040.
    PubMed     Abstract available


  47. FOLEY J, Burns CL, Ward EC, Nund RL, et al
    Post-acute health care needs of people with head and neck cancer: Mapping health care services, experiences, and the impact of rurality.
    Head Neck. 2022 Mar 23. doi: 10.1002/hed.27037.
    PubMed     Abstract available


  48. GILLEY DR, Clark AD, Wieser ME, Bollig CA, et al
    Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.
    Head Neck. 2022 Mar 22. doi: 10.1002/hed.27035.
    PubMed     Abstract available


  49. ZENGA J, Awan MJ, Frei A, Petrie E, et al
    Chronic stress promotes an immunologic inflammatory state and head and neck cancer growth in a humanized murine model.
    Head Neck. 2022 Mar 8. doi: 10.1002/hed.27028.
    PubMed     Abstract available


  50. AL-QURAYSHI Z, Ngouajio AL, Buchakjian MR
    Presentation and outcomes of patients with clinically T1-2, N0 supraglottic squamous cell carcinoma: The role of definitive radiotherapy compared to primary partial laryngectomy.
    Head Neck. 2022;44:735-744.
    PubMed     Abstract available


  51. FENLON JB, Hutten RJ, Weil CR, Lloyd S, et al
    Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins.
    Head Neck. 2022;44:606-614.
    PubMed     Abstract available


  52. HU JQ, Yu PC, Tan LC, Wei WJ, et al
    A novel method to reconstruct right recurrent laryngeal nerve by transforming into nonrecurrent laryngeal nerve: The end-to-free vagal laryngeal branch end anastomosis.
    Head Neck. 2022;44:805-809.
    PubMed     Abstract available


    February 2022
  53. MICHMERHUIZEN NL, Ludwig ML, Birkeland AC, Nimmagadda S, et al
    Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27018.
    PubMed     Abstract available


  54. ALZAHRANI F, Sahovaler A, Mundi N, Rammal A, et al
    Transoral robotic surgery for the identification of unknown primary head and neck squamous cell carcinomas: Its effect on the wait and the weight.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27023.
    PubMed     Abstract available


  55. SCHACHTEL MJC, Gandhi M, Bowman JJ, Porceddu SV, et al
    Facial nerve perineural spread from cutaneous squamous cell carcinoma of the head and neck: A single institution analysis of epidemiology, treatment, survival outcomes, and prognostic factors.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27017.
    PubMed     Abstract available


  56. JIANG YT, Chen KH, Yang J, Liang ZG, et al
    Prognostic significance of wait time for radical radiotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 26. doi: 10.1002/hed.27011.
    PubMed     Abstract available


  57. JIANG YT, Chen KH, Liang ZG, Yang J, et al
    A nomogram based on tumor response to induction chemotherapy may predict survival in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 25. doi: 10.1002/hed.27020.
    PubMed     Abstract available


  58. KIM HAJ, Zeng PYF, Sorgini A, Shaikh MH, et al
    Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.
    Head Neck. 2022 Feb 21. doi: 10.1002/hed.27007.
    PubMed     Abstract available


  59. WENG JJ, Wei JZ, Li M, Ning LP, et al
    Prognostic value of hypothyroidism in patients undergoing intensity-modulated radiation therapy for nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 16. doi: 10.1002/hed.27006.
    PubMed     Abstract available


  60. LIN W, Cao D, Dong A, Liang S, et al
    Systematic construction and external validation of an immune-related prognostic model for nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 15. doi: 10.1002/hed.26996.
    PubMed     Abstract available


  61. NIGHTINGALE J, Gandhi M, Helena J, Bowman J, et al
    Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: Time to rethink treatment paradigms.
    Head Neck. 2022 Feb 13. doi: 10.1002/hed.27005.
    PubMed     Abstract available


  62. YANG ZC, Luo MJ, Sun XS, Liu LT, et al
    Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study.
    Head Neck. 2022 Feb 10. doi: 10.1002/hed.26999.
    PubMed     Abstract available


  63. TAKENAKA Y, Oya R, Takemoto N, Inohara H, et al
    Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta-analysis.
    Head Neck. 2022 Feb 10. doi: 10.1002/hed.26997.
    PubMed     Abstract available


  64. VANGELOV B, Bauer J, Moses D, Smee R, et al
    The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
    Head Neck. 2022 Feb 9. doi: 10.1002/hed.27000.
    PubMed     Abstract available


  65. BARRETTE LX, De Ravin E, Carey RM, Mady LJ, et al
    Reconstruction following transoral robotic surgery for head and neck cancer: Systematic review.
    Head Neck. 2022 Feb 9. doi: 10.1002/hed.26998.
    PubMed     Abstract available


  66. STEPHEN SE, Murphy JM, Beyer FR, Sellstrom D, et al
    Early postoperative functional outcomes following transoral surgery for oropharyngeal cancer: A systematic review.
    Head Neck. 2022;44:530-547.
    PubMed     Abstract available


  67. DHERE VR, Escott CE, Tian S, Switchenko JM, et al
    The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures.
    Head Neck. 2022;44:382-390.
    PubMed     Abstract available


  68. SINCLAIR CF, Buczek E, Cottril E, Angelos P, et al
    Clarifying optimal outcome measures in intermittent and continuous laryngeal neuromonitoring.
    Head Neck. 2022;44:460-471.
    PubMed     Abstract available


  69. WITEK ME, Woody NM, Musunuru HB, Hill PM, et al
    Defining high-risk elective contralateral neck radiation volumes for oropharynx cancer.
    Head Neck. 2022;44:317-324.
    PubMed     Abstract available


  70. BRIL SI, Chargi N, Pezier TF, Tijink BM, et al
    Arterial calcification on preoperative computed tomography imaging as a risk factor for pharyngocutaneous fistula formation after total laryngectomy.
    Head Neck. 2022;44:307-316.
    PubMed     Abstract available


    January 2022
  71. SINGH M, Thankappan K, Balasubramanian D, Pillai V, et al
    Incorporation of adverse features in advanced oral cancer improves precision in staging and patient prognostication.
    Head Neck. 2022 Jan 31. doi: 10.1002/hed.26990.
    PubMed     Abstract available


  72. DEUNING-SMIT E, Custers JAE, Mirosevic S, Takes RP, et al
    Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: Course, trajectories, and associated factors.
    Head Neck. 2022 Jan 27. doi: 10.1002/hed.26985.
    PubMed     Abstract available


  73. HOYLE JM, Correya TA, Kenzik K, Francisco L, et al
    Factors associated with loss to follow-up after radiation therapy for head and neck cancer.
    Head Neck. 2022 Jan 25. doi: 10.1002/hed.26986.
    PubMed     Abstract available


  74. LIU X, Wu B, Huang J, Qin Y, et al
    Tumor factors associated with in-field failure for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Head Neck. 2022 Jan 24. doi: 10.1002/hed.26983.
    PubMed     Abstract available


  75. TUOMI L, Dotevall H, Bergquist H, Petersson K, et al
    The effect of the Shaker head-lift exercise on swallowing function following treatment for head and neck cancer: Results from a randomized, controlled trial with videofluoroscopic evaluation.
    Head Neck. 2022 Jan 23. doi: 10.1002/hed.26982.
    PubMed     Abstract available


  76. GAO P, Peng W, Hu Y
    Prognostic and clinicopathological significance of lymphocyte-to-monocyte ratio in patients with nasopharyngeal carcinoma: A meta-analysis.
    Head Neck. 2022 Jan 20. doi: 10.1002/hed.26952.
    PubMed     Abstract available


  77. EMERSON MA, Farquhar DR, Lenze NR, Sheth S, et al
    Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients.
    Head Neck. 2022 Jan 19. doi: 10.1002/hed.26977.
    PubMed     Abstract available


  78. MASCARELLA MA, Patel T, Vendra V, Gardiner L, et al
    Poor treatment tolerance in head and neck cancer patients with low muscle mass.
    Head Neck. 2022 Jan 12. doi: 10.1002/hed.26978.
    PubMed     Abstract available


  79. MEULEMANS J, Vanermen M, Goeleven A, Clement P, et al
    Transoral robotic surgery (TORS) using the da Vinci Xi: prospective analysis of feasibility, safety, and outcomes.
    Head Neck. 2022;44:143-157.
    PubMed     Abstract available


  80. WOISARD V, Balaguer M, Fredouille C, Farinas J, et al
    Construction of an automatic score for the evaluation of speech disorders among patients treated for a cancer of the oral cavity or the oropharynx: The Carcinologic Speech Severity Index.
    Head Neck. 2022;44:71-88.
    PubMed     Abstract available


  81. BIGELOW EO, Harris J, Fakhry C, Gillison ML, et al
    Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522.
    Head Neck. 2022;44:158-167.
    PubMed     Abstract available


  82. YANG ZC, Du CC, Liu T, Liu LT, et al
    Management of first-line palliative chemotherapy for post-treatment metastasis after gemcitabine plus cisplatin induction chemotherapy: Gemcitabine plus cisplatin and non-gemcitabine plus cisplatin chemotherapy.
    Head Neck. 2022;44:113-121.
    PubMed     Abstract available


  83. TAN BKJ, Raghupathy J, Song HJJMD, Yeo BSY, et al
    Trainee participation does not adversely affect the safety of thyroid surgery: Systematic review and meta-analysis.
    Head Neck. 2022;44:262-274.
    PubMed     Abstract available


  84. RE M, Tomasetti M, Monaco F, Amati M, et al
    MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma.
    Head Neck. 2022;44:18-33.
    PubMed     Abstract available


    December 2021
  85. YANG L, Xue Y, Wei Z, Ren K, et al
    Local radiotherapy versus nonradiotherapy to distant lesions for metastatic nasopharyngeal carcinoma: A retrospective cohort study.
    Head Neck. 2021 Dec 27. doi: 10.1002/hed.26953.
    PubMed     Abstract available


  86. LANE C, Myers C, Jiang D, Cooke A, et al
    Selected functional outcomes in advanced oral cancer: Comparison of surgery alone versus surgery with postoperative radiotherapy.
    Head Neck. 2021 Dec 23. doi: 10.1002/hed.26968.
    PubMed     Abstract available



  87. Magnetic resonance imaging-based radiogenomics analysis for predicting prognosis and gene expression profile in advanced nasopharyngeal carcinoma.
    Head Neck. 2021 Dec 22. doi: 10.1002/hed.26947.
    PubMed    


  88. MCCUSKER MG, Mehra R, Amr S, Taylor RJ, et al
    Comparison of efficacy and toxicity of chemoradiation regimens for head and neck squamous cell carcinoma primary treatment.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26965.
    PubMed     Abstract available


  89. LI W, Xu R, Zhu B, Wang H, et al
    Circular RNAs: Functions and mechanisms in nasopharyngeal carcinoma.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26962.
    PubMed     Abstract available


  90. ROSAS RR, Nachbor KM, Handley N, Mathison G, et al
    Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26959.
    PubMed     Abstract available


  91. KIM MS, Malik NH, Chen H, Poon I, et al
    Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review.
    Head Neck. 2021 Dec 19. doi: 10.1002/hed.26948.
    PubMed     Abstract available


  92. SUN Y, Pan H, He Y, Hu C, et al
    Functional roles of the SHCBP1 and KIF23 interaction in modulating the cell-cycle and cisplatin resistance of head and neck squamous cell carcinoma.
    Head Neck. 2021 Dec 17. doi: 10.1002/hed.26961.
    PubMed     Abstract available


  93. HAN SH, Cho D, Mohammad R, Jung YH, et al
    Use of the comprehensive geriatric assessment for the prediction of postoperative complications in elderly patients with head and neck cancer.
    Head Neck. 2021 Dec 17. doi: 10.1002/hed.26958.
    PubMed     Abstract available


  94. LERE-CHEVALEYRE A, Bernadach M, Lambert C, Cassagne L, et al
    Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle mass.
    Head Neck. 2021 Dec 16. doi: 10.1002/hed.26954.
    PubMed     Abstract available


  95. SHEHAN JN, Alwani T, LeClair J, Mahoney TF, et al
    Social determinants of health and treatment decisions in head and neck cancer.
    Head Neck. 2021 Dec 10. doi: 10.1002/hed.26931.
    PubMed     Abstract available


  96. LIU T, Dai S, Zhang H, Zhong X, et al
    The best choice of induction chemotherapy for patients with locally advanced nasopharyngeal carcinoma: Bayesian network meta-analysis.
    Head Neck. 2021 Dec 4. doi: 10.1002/hed.26932.
    PubMed     Abstract available


  97. YAN F, Lao WP, Nguyen SA, Sharma AK, et al
    Elective neck dissection in salivary gland malignancies: Systematic review and meta-analysis.
    Head Neck. 2021 Dec 4. doi: 10.1002/hed.26923.
    PubMed     Abstract available


  98. JEANS EB, Shiraishi S, Manzar G, Morris LK, et al
    An comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.
    Head Neck. 2021 Dec 3. doi: 10.1002/hed.26937.
    PubMed     Abstract available


  99. CHOI HW, Ji YB, Kim E, Kim KN, et al
    Success rate and learning curve of intraoperative neural monitoring of the external branch of the superior laryngeal nerve in thyroidectomy.
    Head Neck. 2021;43:3946-3954.
    PubMed     Abstract available


  100. MEHTA MP, Prince R, Butt Z, Maxwell BE, et al
    Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer.
    Head Neck. 2021;43:3955-3965.
    PubMed     Abstract available


  101. RYBKIN A, Kang JJ, Lee A, Kitpanit S, et al
    The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers.
    Head Neck. 2021;43:3796-3809.
    PubMed     Abstract available


  102. BERG M, Adnan A, Hogmo A, Sjodin H, et al
    A national study of health-related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma.
    Head Neck. 2021;43:3843-3856.
    PubMed     Abstract available


  103. SOUSA LG, Lazar Neto F, Torman DK, Diaz EM, et al
    Therapeutic approaches and outcomes in patients with larynx or hypopharynx high-grade neuroendocrine carcinoma: A single-center retrospective analysis.
    Head Neck. 2021;43:3788-3795.
    PubMed     Abstract available


  104. NEWTON E, Valenzuela D, Foley J, Thamboo A, et al
    Outcomes for the treatment of locoregional recurrent nasopharyngeal cancer: Systematic review and pooled analysis.
    Head Neck. 2021;43:3979-3995.
    PubMed     Abstract available


  105. KU D, Hui M, Cheung P, Chow O, et al
    Meta-analysis on continuous nerve monitoring in thyroidectomies.
    Head Neck. 2021;43:3966-3978.
    PubMed     Abstract available


    November 2021
  106. RAVIKUMAR S, Casellas NJ, Shah S, Rieth K, et al
    Geographic disparities in head and neck cancer survival in Upstate New York 2011-2019.
    Head Neck. 2021 Nov 29. doi: 10.1002/hed.26945.
    PubMed     Abstract available


  107. FENG X, Zhang T, Chou J, Liu L, et al
    Comprehensive gene cluster analysis of head and neck squamous cell carcinoma TCGA RNA-seq data defines B cell immunity-related genes as a robust survival predictor.
    Head Neck. 2021 Nov 29. doi: 10.1002/hed.26944.
    PubMed     Abstract available


  108. AMIN N, Maroun CA, El Asmar M, Alkhatib HH, et al
    Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic review.
    Head Neck. 2021 Nov 26. doi: 10.1002/hed.26935.
    PubMed     Abstract available


  109. LI G, Xia YF, Huang YX, Okat D, et al
    Intensity-modulated proton radiation therapy as a radical treatment modality for nasopharyngeal carcinoma in China: A cost-effectiveness analysis.
    Head Neck. 2021 Nov 26. doi: 10.1002/hed.26941.
    PubMed     Abstract available


  110. CHARTERS E, Bogaardt H, Clark J, Milross C, et al
    Functional swallowing outcomes related to radiation exposure to dysphagia and aspiration-related structures in patients with head and neck cancer undergoing definitive and postoperative intensity-modulated radiotherapy.
    Head Neck. 2021 Nov 22. doi: 10.1002/hed.26936.
    PubMed     Abstract available


  111. PIAI V, Jansen F, Dahlslatt K, Verdonck-de Leeuw IM, et al
    Prevalence of neurocognitive and perceived speech deficits in patients with head and neck cancer before treatment: Associations with demographic, behavioral, and disease-related factors.
    Head Neck. 2021 Nov 19. doi: 10.1002/hed.26930.
    PubMed     Abstract available


  112. LENZE NR, Bensen JT, Farnan L, Sheth S, et al
    Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer.
    Head Neck. 2021 Nov 18. doi: 10.1002/hed.26934.
    PubMed     Abstract available


  113. WU EL, Peesay T, Randall JA, Nelson LL, et al
    Increased body mass index predicts prolonged survival in patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26922.
    PubMed     Abstract available


  114. DIAO K, Wang H, Phan J
    Reply to Letter to the Editor regarding 'Stereotactic radiotherapy for reirradiation of head and neck cancer: Dosimetric details matter'.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26920.
    PubMed    


  115. WEST N, Kelly C, Kovarik J, Iqbal MS, et al
    Stereotactic radiotherapy for reirradiation of head and neck cancer: Dosimetric details matter.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26925.
    PubMed    


  116. IOCCA O, Copelli C, Ramieri G, Zocchi J, et al
    Antibiotic prophylaxis in head and neck cancer surgery: Systematic review and Bayesian network meta-analysis.
    Head Neck. 2021 Nov 6. doi: 10.1002/hed.26908.
    PubMed     Abstract available


  117. JING Z, Guo S, Li Y, Liang Z, et al
    FOXC2/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cells.
    Head Neck. 2021 Nov 3. doi: 10.1002/hed.26918.
    PubMed     Abstract available


  118. BULBUL MG, Genovese TJ, Hagan K, Rege S, et al
    Salvage surgery for recurrent squamous cell carcinoma of the head and neck: Systematic review and meta-analysis.
    Head Neck. 2021 Nov 3. doi: 10.1002/hed.26898.
    PubMed     Abstract available


  119. SICHERO L, Tagliabue M, Mota G, Ferreira S, et al
    Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status.
    Head Neck. 2021 Nov 2. doi: 10.1002/hed.26912.
    PubMed     Abstract available


  120. MIRZA FA, Johnson CZ, Byrd JK, Albergotti WG 3rd, et al
    Treatment trends for advanced oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Head Neck. 2021;43:3476-3492.
    PubMed     Abstract available


  121. FANTINI M, Crosetti E, Affaniti R, Sprio AE, et al
    Preoperative prognostic factors for functional and clinical outcomes after open partial horizontal laryngectomies.
    Head Neck. 2021;43:3459-3467.
    PubMed     Abstract available


  122. AMINI A, Morgan R, Meyer E, Fakhoury K, et al
    Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer.
    Head Neck. 2021;43:3393-3403.
    PubMed     Abstract available


  123. SOLIMENO LS, Park YM, Lim JY, Koh YW, et al
    Treatment outcomes of neoadjuvant chemotherapy and transoral robotic surgery in locoregionally advanced laryngopharyngeal carcinoma.
    Head Neck. 2021;43:3429-3436.
    PubMed     Abstract available


  124. OBERSTE M, Riders A, Abbaspour B, Kerschke L, et al
    Improvement of patient stratification in human papilloma virus-associated oropharyngeal squamous cell carcinoma by defining a multivariable risk score.
    Head Neck. 2021;43:3314-3323.
    PubMed     Abstract available


  125. SMITH DH, Raslan S, Samuels MA, Iglesias T, et al
    Current salivary biomarkers for detection of human papilloma virus-induced oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:3618-3630.
    PubMed     Abstract available


  126. DAY AT, Yang AM, Tanamal P, Blackwell JM, et al
    Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: National hospital-based retrospective cohort analysis.
    Head Neck. 2021;43:3345-3363.
    PubMed     Abstract available


  127. QUAN DL, Sukari A, Nagasaka M, Kim H, et al
    Gastrostomy tube dependence and patient-reported quality of life outcomes based on type of treatment for human papillomavirus-associated oropharyngeal cancer: Systematic review and meta-analysis.
    Head Neck. 2021;43:3681-3696.
    PubMed     Abstract available


  128. ZAKRZEWSKI M, Gannon OM, Panizza BJ, Saunders NA, et al
    Human papillomavirus infection and tumor microenvironment are associated with the microbiota in patients with oropharyngeal cancers-pilot study.
    Head Neck. 2021;43:3324-3330.
    PubMed     Abstract available


  129. ANAKAPU K, Wilson M, Findlay M, Brown T, et al
    Nutritional outcomes in patients undergoing transoral robotic surgery for head and neck cancers compared to conventional open surgery. A systematic review.
    Head Neck. 2021 Nov 1. doi: 10.1002/hed.26913.
    PubMed     Abstract available


    October 2021
  130. BRIL SI, Al-Mamgani A, Chargi N, Remeijer P, et al
    The association of pretreatment low skeletal muscle mass with chemotherapy dose-limiting toxicity in patients with head and neck cancer undergoing primary chemoradiotherapy with high-dose cisplatin.
    Head Neck. 2021 Oct 29. doi: 10.1002/hed.26919.
    PubMed     Abstract available


  131. SULTANIA M, Imaduddin M, S V Deo S, Kar M, et al
    Role of metronomic therapy for advanced oral cancers and predictors of response: A multi-institutional feasibility study.
    Head Neck. 2021 Oct 28. doi: 10.1002/hed.26904.
    PubMed     Abstract available


  132. ZHOU C, Cao H, Meng X, Zhang Q, et al
    Lnc-MEG3 inhibits invasion, migration, and epithelial- mesenchymal transition of nasopharyngeal carcinoma cells by regulating sequestosome 1.
    Head Neck. 2021 Oct 27. doi: 10.1002/hed.26917.
    PubMed     Abstract available


  133. NALLANI R, Smith JB, Penn JP, Bur AM, et al
    Decision regret 3 and 6 months after treatment for head and neck cancer: An observational study of associations with clinicodemographics, anxiety, and quality of life.
    Head Neck. 2021 Oct 27. doi: 10.1002/hed.26911.
    PubMed     Abstract available


  134. CHINTALA S, Quist KM, Gonzalez-DeWhitt PA, Katzenellenbogen RA, et al
    High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas.
    Head Neck. 2021 Oct 25. doi: 10.1002/hed.26906.
    PubMed     Abstract available


  135. LIU LT, Liang YJ, Guo SS, Xie Y, et al
    Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: A study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein-Barr virus DNA.
    Head Neck. 2021 Oct 12. doi: 10.1002/hed.26897.
    PubMed     Abstract available


  136. AMR S, Ioffe D, Suzuki I, Mehra R, et al
    Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Oct 10. doi: 10.1002/hed.26893.
    PubMed     Abstract available


  137. COGNETTI DM, Johnson JM, Curry JM, Kochuparambil ST, et al
    Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.
    Head Neck. 2021 Oct 9. doi: 10.1002/hed.26885.
    PubMed     Abstract available


  138. LOU DI, Dietrich MS, Deng J, Murphy BA, et al
    Mechanisms of pain and their manifestations in head and neck cancer: Importance of classifying pain subtypes.
    Head Neck. 2021 Oct 7. doi: 10.1002/hed.26859.
    PubMed     Abstract available


  139. LARSEN MHH, Scott SI, Channir HI, Madsen AKO, et al
    Days alive and out of hospital following transoral robotic surgery: Cohort study of 262 patients with head and neck cancer.
    Head Neck. 2021 Oct 3. doi: 10.1002/hed.26880.
    PubMed     Abstract available


  140. HOLCOMB AJ, Richmon JD
    Surgical margins in a single-modality transoral robotic surgery: A conundrum-Reply.
    Head Neck. 2021;43:3219-3221.
    PubMed    


  141. SHAH SB, Malik A
    Surgical margins in a single modality transoral robotic surgery-A conundrum.
    Head Neck. 2021;43:3217-3218.
    PubMed    


  142. BASTERRA J, Oishi N, Lopez I, Otero M, et al
    Use of monopolar microelectrodes and radiofrequency in the treatment of arytenoid edema after partial horizontal laryngectomy and radiotherapy.
    Head Neck. 2021;43:3245-3248.
    PubMed     Abstract available


  143. WINDON MJ, Fakhry C, Margalit DN, Dey T, et al
    Epidemiologic distinctions between base of tongue and tonsil oropharyngeal carcinomas.
    Head Neck. 2021;43:3076-3085.
    PubMed     Abstract available


  144. UEHARA T, Doi H, Ishikawa K, Inada M, et al
    Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors.
    Head Neck. 2021;43:3132-3141.
    PubMed     Abstract available


  145. SHUKLA N, Ma Y, Megwalu UC
    The role of insurance status as a mediator of racial disparities in oropharyngeal cancer outcomes.
    Head Neck. 2021;43:3116-3124.
    PubMed     Abstract available


  146. SUN L, Shimunov D, Tan EX, Swisher-Mcclure S, et al
    Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery.
    Head Neck. 2021;43:3053-3061.
    PubMed     Abstract available


  147. ROWE LM, Connor NP, Russell JA
    Respiratory-swallow coordination in a rat model of chemoradiation.
    Head Neck. 2021;43:2954-2966.
    PubMed     Abstract available


  148. MENDELSOHN AH, Lawson G
    Single-port transoral robotic surgery hypopharyngectomy.
    Head Neck. 2021;43:3234-3237.
    PubMed     Abstract available


  149. GAINO F, Gorphe P, Vander Poorten V, Holsinger FC, et al
    Preoperative predictors of difficult oropharyngeal exposure for transoral robotic surgery: The Pharyngoscore.
    Head Neck. 2021;43:3010-3021.
    PubMed     Abstract available


  150. LOW CM, Balakrishnan K, Smith BM, Stokken JK, et al
    Sinonasal adenocarcinoma: Population-based analysis of demographic and socioeconomic disparities.
    Head Neck. 2021;43:2946-2953.
    PubMed     Abstract available


  151. PARHAR HS, Weinstein GS, O'Malley BW Jr, Shimunov D, et al
    Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
    Head Neck. 2021;43:2923-2934.
    PubMed     Abstract available


  152. BARBON CEA, Yao CMKL, Alvarez CP, Goepfert RP, et al
    Dysphagia profiles after primary transoral robotic surgery or radiation for oropharyngeal cancer: A registry analysis.
    Head Neck. 2021;43:2883-2895.
    PubMed     Abstract available


  153. THAKAR A, Panda S, Kakkar A, Singh V, et al
    A matched pair analysis of oncological outcomes in human papillomavirus-negative oropharyngeal squamous cell carcinoma: Transoral surgery versus radiotherapy or concurrent chemoradiation.
    Head Neck. 2021;43:2896-2906.
    PubMed     Abstract available


    September 2021
  154. SANABRIA A, Pinillos P, Lira RB, Shah JP, et al
    Current therapeutic options for low-risk papillary thyroid carcinoma: A scoping evidence review.
    Head Neck. 2021 Sep 30. doi: 10.1002/hed.26883.
    PubMed     Abstract available


  155. VILASECA I, Aviles-Jurado FX, Valduvieco I, Berenguer J, et al
    Transoral laser microsurgery in locally advanced laryngeal cancer: Prognostic impact of anterior versus posterior compartments.
    Head Neck. 2021 Sep 27. doi: 10.1002/hed.26878.
    PubMed     Abstract available


  156. FENG G, Wang T, Xue F, Qi Y, et al
    Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma.
    Head Neck. 2021 Sep 27. doi: 10.1002/hed.26877.
    PubMed     Abstract available


  157. XU X, Ong YK, Loh WS, Anil G, et al
    Clinical predictors of internal carotid artery blowout in patients with radiated nasopharyngeal carcinoma.
    Head Neck. 2021 Sep 24. doi: 10.1002/hed.26869.
    PubMed     Abstract available


  158. SATO MP, Otsuki N, Kitano M, Ishikawa K, et al
    Up-front neck dissection followed by chemoradiotherapy for T1-T3 hypopharyngeal cancer with advanced nodal involvement.
    Head Neck. 2021 Sep 22. doi: 10.1002/hed.26881.
    PubMed     Abstract available


  159. VAN DER ELST S, Bardash Y, Wotman M, Kraus D, et al
    The prognostic impact of depression or depressive symptoms on patients with head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2021 Sep 15. doi: 10.1002/hed.26868.
    PubMed     Abstract available


  160. KU PKM, Vlantis AC, Hui TSC, Yeung DCM, et al
    Assessment of pharyngeal motor function using a novel velopharyngeal squeeze maneuver and a novel endoscopic pharyngeal contraction grade scale in patients with dysphagia after radiotherapy for nasopharyngeal carcinoma.
    Head Neck. 2021 Sep 15. doi: 10.1002/hed.26871.
    PubMed     Abstract available


  161. GAO Y, Mao Y, Lu S, Tan L, et al
    Magnetic resonance imaging-based radiogenomics analysis for predicting prognosis and gene expression profile in advanced nasopharyngeal carcinoma.
    Head Neck. 2021 Sep 13. doi: 10.1002/hed.26867.
    PubMed     Abstract available


  162. METZGER K, Mrosek J, Zittel S, Pilz M, et al
    Treatment delay and tumor size in patients with oral cancer during the first year of the COVID-19 pandemic.
    Head Neck. 2021 Sep 8. doi: 10.1002/hed.26858.
    PubMed     Abstract available


  163. SINGH P, McDonald L, Waldenberger D, Welslau M, et al
    Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and Germany.
    Head Neck. 2021 Sep 6. doi: 10.1002/hed.26853.
    PubMed     Abstract available


  164. SINGH A, Rosen EB, Randazzo JD, Estilo CL, et al
    Intraoral radiation stents-Primer for clinical use in head and neck cancer therapy.
    Head Neck. 2021 Sep 4. doi: 10.1002/hed.26848.
    PubMed     Abstract available


  165. FOLEY J, Ward EC, Burns CL, Nund RL, et al
    Speech pathology service enhancement for people with head and neck cancer living in rural areas: Using a concept mapping approach to inform service change.
    Head Neck. 2021 Sep 3. doi: 10.1002/hed.26850.
    PubMed     Abstract available


  166. HORWICH P, Gundale A, Patin S, Flores J, et al
    Impact of smoking on stage-specific survival in human papilloma virus-associated oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2698-2704.
    PubMed     Abstract available


  167. YU L, Zheng M, Ren J, Hu J, et al
    Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for patients with laryngeal cicatricial stenosis: Safety and efficacy.
    Head Neck. 2021;43:2634-2643.
    PubMed     Abstract available


    August 2021
  168. GEARING PF, Daly JF, Tang NSJ, Singh K, et al
    Risk factors for surgical site infection in free-flap reconstructive surgery for head and neck cancer: A retrospective Australian cohort study.
    Head Neck. 2021 Aug 18. doi: 10.1002/hed.26837.
    PubMed     Abstract available


  169. BHOLA NE, Njatcha C, Hu L, Lee ED, et al
    PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance.
    Head Neck. 2021 Aug 3. doi: 10.1002/hed.26827.
    PubMed     Abstract available


  170. HAYDEN RE, Chang BA, Mullin DP, Patel AK, et al
    Reply to Letter to the Editor regarding "Surgical armamentarium for salvage laryngectomy closure reinforcements".
    Head Neck. 2021;43:2559.
    PubMed    


  171. HOLCOMB AJ, Herberg M, Strohl M, Ochoa E, et al
    Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2434-2444.
    PubMed     Abstract available


  172. STEINBICHLER TB, Wolfram D, Runge A, Hartl R, et al
    Modified vacuum-assisted closure (EndoVAC) therapy for treatment of pharyngocutaneous fistula: Case series and a review of the literature.
    Head Neck. 2021;43:2377-2384.
    PubMed     Abstract available


    July 2021
  173. STOKES WA, Molina E, McDermott JD, Morgan RL, et al
    Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26809.
    PubMed     Abstract available


  174. SCHLIJPER R, Bos S, Hamilton SN, Tran E, et al
    Ninety-day mortality after radiotherapy for head and neck cancer: A population-based comparison between rural and urban patients.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26819.
    PubMed     Abstract available


  175. KIM MJ, Back K, Choe JH, Kim JH, et al
    Feasibility of lateral sentinel lymph node biopsy in medullary thyroid cancer: A surrogate tool for determining prophylactic lateral neck dissection-A pilot study.
    Head Neck. 2021 Jul 20. doi: 10.1002/hed.26808.
    PubMed     Abstract available


  176. DIAO K, Nguyen TP, Moreno AC, Reddy JP, et al
    Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: A large, single-institution, modern cohort study.
    Head Neck. 2021 Jul 16. doi: 10.1002/hed.26820.
    PubMed     Abstract available


  177. THANKAPPAN K, Subramanian S, Balasubramanian D, Kuriakose MA, et al
    Cost-effectiveness of oral cancer screening approaches by visual examination: A systematic review.
    Head Neck. 2021 Jul 14. doi: 10.1002/hed.26816.
    PubMed     Abstract available


  178. DING Z, Li Y, Pan X, Xuan M, et al
    Sentinel lymph node biopsy versus elective neck dissection in squamous cell carcinoma of the oral cavity with a clinically N0 neck: A systematic review and meta-analysis of prospective studies.
    Head Neck. 2021 Jul 10. doi: 10.1002/hed.26803.
    PubMed     Abstract available


  179. SHIGA K, Nibu KI, Fujimoto Y, Asakage T, et al
    Sites of invasion of cancer of the external auditory canal predicting oncologic outcomes.
    Head Neck. 2021 Jul 9. doi: 10.1002/hed.26800.
    PubMed     Abstract available


  180. REID P, Staudacher AH, Marcu LG, Olver I, et al
    Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26802.
    PubMed     Abstract available


  181. BADDOUR K, Fadel M, Zhao M, Corcoran M, et al
    The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26801.
    PubMed     Abstract available


  182. CHILLAKURU Y, Benito DA, Strum D, Mehta V, et al
    Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2259-2273.
    PubMed     Abstract available


  183. PFISTER NT, Beitler JJ, Stokes WA
    Contralateral nodal spread in human papillomavirus-associated oropharyngeal cancer: Can more details help guide contralateral neck coverage?
    Head Neck. 2021;43:2253.
    PubMed    


  184. HUSAIN S, Lohia S, Petkov V, Blackwell T, et al
    Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER.
    Head Neck. 2021;43:2110-2123.
    PubMed     Abstract available


  185. CHEN L, Lin G, Qian J, Chen Z, et al
    A dynamic prognostic nomogram to predict the benefit from surgical treatment modality for patients with laryngeal squamous cell carcinoma.
    Head Neck. 2021;43:2148-2158.
    PubMed     Abstract available


  186. TOMBLINSON CM, Fletcher GP, Hu LS, Mi L, et al
    Determination of posterolateral oropharyngeal wall thickness and the potential implications for transoral surgical margins in tonsil cancer.
    Head Neck. 2021;43:2185-2192.
    PubMed     Abstract available


  187. SAIYED FK, Guo T, Johnson F, Myers JN, et al
    Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2101-2109.
    PubMed     Abstract available


  188. CHARTERS E, Wu R, Milross C, Bogaardt H, et al
    Swallowing and communication outcomes following primary transoral robotic surgery.
    Head Neck. 2021;43:2013-2023.
    PubMed     Abstract available


  189. LASKAR SG, Pai P, Sinha S, Budrukkar A, et al
    Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single institute.
    Head Neck. 2021;43:2045-2057.
    PubMed     Abstract available


    June 2021
  190. GAO J, Tseng CC, Barinsky GL, Povolotskiy R, et al
    Exploratory analysis on the association of mental health disorders with in-hospital postoperative complications and mortality in head and neck cancer surgery.
    Head Neck. 2021 Jun 28. doi: 10.1002/hed.26791.
    PubMed     Abstract available


  191. BURBURE N, Handorf E, Ridge JA, Bauman J, et al
    Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer.
    Head Neck. 2021 Jun 24. doi: 10.1002/hed.26793.
    PubMed     Abstract available


  192. FATEHI KS, Malik A
    Elective neck dissection and its extent in salivary gland cancers: A dilemma.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26777.
    PubMed    


  193. WESTERGAARD-NIELSEN M, Godballe C, Eriksen JG, Larsen SR, et al
    Reply to Letter to the Editor regarding "Elective neck dissection and its extent in Salivary gland cancers: A Dilemma".
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26778.
    PubMed    


  194. RICH BJ, Schumacher LD, Sargi ZB, Masforroll M, et al
    Opioid use patterns in patients with head and neck cancer receiving radiation therapy: A single-institution retrospective analysis characterizing patients who did not require opioid therapy.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26785.
    PubMed     Abstract available


  195. WEIZMAN B, Golan N, Ronen O
    Effect of socioeconomic status on survival in patients with head and neck cancer.
    Head Neck. 2021 Jun 16. doi: 10.1002/hed.26788.
    PubMed     Abstract available


  196. BERGAMINI C, Ferris RL, Xie J, Mariani G, et al
    Bleeding complications in patients with squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Jun 12. doi: 10.1002/hed.26772.
    PubMed     Abstract available


  197. CAVALHEIRO BG, de Matos LL, Leite AKN, Kulcsar MAV, et al
    Survival in differentiated thyroid carcinoma: A comparison between the 7th and 8th editions of the AJCC/UICC TNM staging system and the ATA initial risk stratification system.
    Head Neck. 2021 Jun 1. doi: 10.1002/hed.26773.
    PubMed     Abstract available


  198. SABIQ F, Huang K, Patel A, Banerjee R, et al
    Novel imaging classification system of nodal disease in human papillomavirus-mediated oropharyngeal squamous cell carcinoma prognostic of patient outcomes.
    Head Neck. 2021;43:1854-1863.
    PubMed     Abstract available


  199. SAMPLE RA, Wood CB, Mazul AL, Barrett TF, et al
    Low-risk human papilloma virus positive oropharyngeal cancer with one positive lymph node: Equivalent outcomes in patients treated with surgery and radiation therapy versus surgery alone.
    Head Neck. 2021;43:1759-1768.
    PubMed     Abstract available


  200. YAVUZ H, Vural O
    Tracheoesophageal puncture closure with annular mucosal flap.
    Head Neck. 2021;43:1705-1710.
    PubMed     Abstract available


    May 2021
  201. FAGAN JJ, Otiti J, Onakoya PA, Diom E, et al
    AfHNS fellowship: A model to improve access to head and neck cancer care in Africa and developing countries.
    Head Neck. 2021 May 29. doi: 10.1002/hed.26770.
    PubMed     Abstract available


  202. YANG S, Yuan ZJ, Zhu YH, Chen X, et al
    lncRNA PVT1 promotes cetuximab resistance of head and neck squamous cell carcinoma cells by inhibiting miR-124-3p.
    Head Neck. 2021 May 25. doi: 10.1002/hed.26742.
    PubMed     Abstract available


  203. CIVANTOS AM, Prasad A, Carey RM, Bur AM, et al
    Palliative care in metastatic head and neck cancer.
    Head Neck. 2021 May 21. doi: 10.1002/hed.26761.
    PubMed     Abstract available


  204. GOSHTASBI K, Abiri A, Lehrich BM, Haidar YM, et al
    The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26739.
    PubMed     Abstract available


  205. PANG J, Faraji F, Risa E, Mell LK, et al
    High rates of postoperative radiotherapy delay in head and neck cancer before and after Medicaid expansion.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26736.
    PubMed     Abstract available


  206. HOESSEINI A, van Leeuwen N, Offerman MPJ, Zhang J, et al
    Predicting survival in head and neck cancer: External validation and update of the prognostic model OncologIQ in 2189 patients.
    Head Neck. 2021 May 7. doi: 10.1002/hed.26716.
    PubMed     Abstract available


  207. RIJO-CEDENO J, Mucientes J, Seijas Marcos S, Romero J, et al
    Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26725.
    PubMed     Abstract available


  208. VERMAIRE JA, Terhaard CHJ, Verdonck-de Leeuw IM, Raaijmakers CPJ, et al
    Reliability of the 100 mL water swallow test in patients with head and neck cancer and healthy subjects.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26723.
    PubMed     Abstract available


  209. LIAO W, He J, Gou Q, Duan B, et al
    Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 May 3. doi: 10.1002/hed.26706.
    PubMed     Abstract available


  210. CHANG JW, Lee S, Lee JM, Moon IS, et al
    Occult parotid involvement in early-stage squamous cell carcinoma of the external auditory canal.
    Head Neck. 2021 May 3. doi: 10.1002/hed.26729.
    PubMed     Abstract available


  211. OTTENSTEIN L, Cornett H, Switchenko JM, Nathan M, et al
    Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma.
    Head Neck. 2021;43:1629-1640.
    PubMed     Abstract available


  212. LIM Y, Tang KD, Karpe AV, Beale DJ, et al
    Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer.
    Head Neck. 2021;43:1521-1534.
    PubMed     Abstract available


  213. YOUNG A, Bigcas JL, Yang A, Reeve N, et al
    Transoral robotic submandibular gland transposition to reconstruct radical tonsillar resection defects.
    Head Neck. 2021;43:1695-1698.
    PubMed     Abstract available


  214. SMITH AW, Gallitto M, Lehrer EJ, Wasserman I, et al
    Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era.
    Head Neck. 2021;43:1409-1414.
    PubMed     Abstract available


  215. MOLTENI G, Gazzini L, Sacchetto A, Nocini R, et al
    Role of the temporoparietal fascia free flap in salvage total laryngectomy.
    Head Neck. 2021;43:1692-1694.
    PubMed     Abstract available


  216. LIU HY, Daniels CP, Trada Y, Bernard A, et al
    The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2021;43:1440-1450.
    PubMed     Abstract available


  217. NOCON CC, Kuchta K, Bhayani MK
    Prognostic value of lymph node ratio versus American Joint Committee on Cancer N classification for surgically resected human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:1476-1486.
    PubMed     Abstract available


    April 2021
  218. XU H, Lu L, Lu T, Xu Y, et al
    Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 Apr 27. doi: 10.1002/hed.26726.
    PubMed     Abstract available


  219. HIGHLAND J, Aylward A, Do O, Monroe M, et al
    Trust in physicians among patients with head and neck cancer before and after treatment.
    Head Neck. 2021 Apr 26. doi: 10.1002/hed.26721.
    PubMed     Abstract available


  220. SEKI-SODA M, Sano T, Ogawa M, Yokoo S, et al
    CD15(+) tumor infiltrating granulocytic cells can predict recurrence and their depletion is accompanied by good responses to S-1 with oral cancer.
    Head Neck. 2021 Apr 24. doi: 10.1002/hed.26712.
    PubMed     Abstract available


  221. NUYTS S, Bollen H, Eisbruch A, Corry J, et al
    Unilateral versus bilateral nodal irradiation: Current evidence in the treatment of squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Apr 19. doi: 10.1002/hed.26713.
    PubMed     Abstract available


  222. MESSING BP, Ward EC, Lazarus C, Ryniak K, et al
    Longitudinal comparisons of a whole-mouth taste test to clinician-rated and patient-reported outcomes of dysgeusia postradiotherapy in patients with head and neck cancer and associations with oral intake.
    Head Neck. 2021 Apr 15. doi: 10.1002/hed.26690.
    PubMed     Abstract available


  223. WANG SM, Yin SC, Su XZ, Xu Q, et al
    Magnitude of radial forearm free flaps and factors associated with loss of volume in oral cancer reconstructive surgery: A prospective study.
    Head Neck. 2021 Apr 13. doi: 10.1002/hed.26704.
    PubMed     Abstract available


  224. WIBONELE BK, Smith BD, Altonji S, Kaplan S, et al
    Head and neck cancer research collaborations between the United States and low- and middle-income countries: A 10-year publication analysis.
    Head Neck. 2021 Apr 5. doi: 10.1002/hed.26703.
    PubMed     Abstract available


  225. YANG N, Mercier E, Guertin L, Bissada E, et al
    Development, translation, and preliminary validation of the neck dissection assessment tool.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26696.
    PubMed     Abstract available


  226. SMITS HJG, Assili S, Kauw F, Philippens MEP, et al
    Prognostic imaging variables for recurrent laryngeal and hypopharyngeal carcinoma treated with primary chemoradiotherapy: A systematic and meta-analysis.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26698.
    PubMed     Abstract available


  227. MILINIS K, Gaskell P, Lau A, Lancaster J, et al
    Early versus late oral feeding following total (pharyngo)laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2021;43:1359-1368.
    PubMed     Abstract available


  228. XING MH, Mundi N, Govindan A, Khorsandi A, et al
    Unusual location of a second branchial cleft cyst presenting in the suprasternal notch.
    Head Neck. 2021;43:E27-E29.
    PubMed     Abstract available


  229. ATALLAH I, Castellanos PF
    Transoral closure of the supraglottic larynx for intractable aspiration.
    Head Neck. 2021;43:1370-1375.
    PubMed     Abstract available


  230. SINHA S, Agarwal JP, Mahajan A, Chaturvedi P, et al
    Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective study.
    Head Neck. 2021;43:1289-1299.
    PubMed     Abstract available


  231. MCKENZIE RM, Parhar HS, Ng TL, Prisman E, et al
    Muscle invasion in oropharyngeal carcinoma undergoing transoral robotic surgery.
    Head Neck. 2021;43:1194-1201.
    PubMed     Abstract available


  232. MATTIOLI F, Fernandez IJ, Bassano E, Luppi MP, et al
    Surgical rehabilitation of swallowing with polydimethylsiloxane injections after open partial horizontal laryngectomy: Long-term functional results and quality of life.
    Head Neck. 2021;43:1161-1173.
    PubMed     Abstract available


  233. CAREY RM, Shimunov D, Weinstein GS, Cannady SB, et al
    Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapy.
    Head Neck. 2021;43:1128-1141.
    PubMed     Abstract available


  234. SUN M, Wang K, Qu Y, Zhang J, et al
    Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis.
    Head Neck. 2021;43:1097-1104.
    PubMed     Abstract available


  235. KUMAR A, Laskar SG, Thiagarajan S
    Is Transoral Robotic Surgery (TORS) for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1376-1377.
    PubMed    


  236. BATES JE, Amdur RJ
    In reply to Kumar et al, Is TORS for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1378-1379.
    PubMed    


    March 2021
  237. GUAN H, He Y, Su Y, Wei Z, et al
    Assessment of different induction chemotherapy regimens in locally advanced nasopharyngeal carcinoma: A meta-analysis.
    Head Neck. 2021 Mar 31. doi: 10.1002/hed.26699.
    PubMed     Abstract available


  238. LI W, Lu H, Wang H, Hu L, et al
    Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis.
    Head Neck. 2021 Mar 29. doi: 10.1002/hed.26687.
    PubMed     Abstract available


  239. NG WT, Tsang RKY, Beitler JJ, de Bree R, et al
    Contemporary management of the neck in nasopharyngeal carcinoma.
    Head Neck. 2021 Mar 29. doi: 10.1002/hed.26685.
    PubMed     Abstract available


  240. EBERSOLE B, McCarroll L, Ridge JA, Liu JC, et al
    Identification and management of late dysfunction in survivors of head and neck cancer: Implementation and outcomes of an interdisciplinary quality of life (IQOL) clinic.
    Head Neck. 2021 Mar 21. doi: 10.1002/hed.26681.
    PubMed     Abstract available


  241. STADLER TM, Morand GB, Rupp NJ, Hullner MW, et al
    FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.
    Head Neck. 2021 Mar 17. doi: 10.1002/hed.26668.
    PubMed     Abstract available


  242. SHAH R, Gosavi V, Mahajan A, Sonawane S, et al
    Preoperative prediction of parathyroid carcinoma in an Asian Indian cohort.
    Head Neck. 2021 Mar 10. doi: 10.1002/hed.26677.
    PubMed     Abstract available


  243. PATEL U, Mittal N, Rane SU, Patil A, et al
    Correlation of transcriptionally active human papillomavirus status with the clinical and molecular profiles of head and neck squamous cell carcinomas.
    Head Neck. 2021 Mar 10. doi: 10.1002/hed.26676.
    PubMed     Abstract available


  244. SAKA-HERRAN C, Jane-Salas E, Estrugo-Devesa A, Lopez-Lopez J, et al
    Head and neck cancer and non-steroidal anti-inflammatory drugs: Systematic review and meta-analysis.
    Head Neck. 2021 Mar 8. doi: 10.1002/hed.26663.
    PubMed     Abstract available


  245. SANSA A, Venegas MDP, Valero C, Pardo L, et al
    The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients.
    Head Neck. 2021 Mar 6. doi: 10.1002/hed.26673.
    PubMed     Abstract available


  246. FASSAS S, Cummings E, Sykes KJ, Bur AM, et al
    Telemedicine for head and neck cancer surveillance in the COVID-19 era: Promise and pitfalls.
    Head Neck. 2021 Mar 4. doi: 10.1002/hed.26659.
    PubMed     Abstract available


  247. WARREN EAK, Anil J, Castro PD, Kemnade J, et al
    Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.
    Head Neck. 2021 Mar 4. doi: 10.1002/hed.26662.
    PubMed     Abstract available


  248. BUGTER O, van Iwaarden DLP, van Leeuwen N, Nieboer D, et al
    A cause-specific Cox model for second primary tumors in patients with head and neck cancer: A RONCDOC study.
    Head Neck. 2021 Mar 3. doi: 10.1002/hed.26666.
    PubMed     Abstract available


  249. KIONG KL, Diaz EM, Gross ND, Diaz EM Jr, et al
    The impact of COVID-19 on head and neck cancer diagnosis and disease extent.
    Head Neck. 2021 Mar 2. doi: 10.1002/hed.26665.
    PubMed     Abstract available


  250. DICKSTEIN DR, Egerman M, Monrose E, Varma A, et al
    Treatment tolerability and outcomes in elderly patients with head and neck cancer.
    Head Neck. 2021;43:858-873.
    PubMed     Abstract available


  251. RITTER A, Hod R, Reuven Y, Shpitzer T, et al
    Role of intraoperative recurrent laryngeal nerve monitoring for pediatric thyroid surgery: Comparative analysis.
    Head Neck. 2021;43:849-857.
    PubMed     Abstract available


    February 2021
  252. LI M, Zhang B, Chen Q, Zhang L, et al
    Concurrent chemoradiotherapy with additional chemotherapy for nasopharyngeal carcinoma: A pooled analysis of propensity score-matching studies.
    Head Neck. 2021 Feb 28. doi: 10.1002/hed.26664.
    PubMed     Abstract available


  253. STEPAN KO, Mazul AL, Skillington SA, Paniello RC, et al
    The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.
    Head Neck. 2021 Feb 23. doi: 10.1002/hed.26639.
    PubMed     Abstract available


  254. VAN DER LANS RJL, Engel MSD, Rijken JA, Hensen EF, et al
    Neuroendocrine neoplasms of the middle ear: Unpredictable tumor behavior and tendency for recurrence.
    Head Neck. 2021 Feb 19. doi: 10.1002/hed.26658.
    PubMed     Abstract available


  255. YANG K, Li M, Zhu J, Zeng L, et al
    Nomograms for predicting survival outcomes in intensity-modulated radiotherapy era of nasopharyngeal carcinoma: A study based on Epstein-Barr virus DNA biological responses.
    Head Neck. 2021 Feb 19. doi: 10.1002/hed.26654.
    PubMed     Abstract available


  256. RAMSEY T, Lee B, Curran K, Desai V, et al
    Associations of insurance, urbanity, and comorbidity with types of palliative care received by patients with head and neck cancer.
    Head Neck. 2021 Feb 18. doi: 10.1002/hed.26648.
    PubMed     Abstract available


  257. RANGABASHYAM M, Koh SQ, Sultana R, Tan NC, et al
    Factors associated with returning to work in head and neck cancer survivors in Singapore: A preliminary exploratory mixed-methods approach study.
    Head Neck. 2021 Feb 18. doi: 10.1002/hed.26644.
    PubMed     Abstract available


  258. FUNG SYH, Chan KCA, Wong EWY, Ng CWK, et al
    Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26647.
    PubMed     Abstract available


  259. SABOUR S, Ghajari H
    Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma: Methodological issues.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26645.
    PubMed    


  260. ELSHARAWI R, Antonucci E, Sukari A, Cramer JD, et al
    Quality metrics for head and neck cancer treated with definitive radiotherapy and/or chemotherapy.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26640.
    PubMed     Abstract available


  261. GUO J, Gui R
    Reply: Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma: Methodological issues (HED-20-22881).
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26652.
    PubMed    


  262. USHINSKY A, Guevara CJ, Kim SK
    Intranodal lymphangiography with thoracic duct embolization for the treatment of chyle leaks after head and neck cancer surgery.
    Head Neck. 2021 Feb 15. doi: 10.1002/hed.26646.
    PubMed     Abstract available


  263. GRECO E, Ringash J, Tomlinson G, Huang SH, et al
    Presence and duration of feeding tube in a 5-year cohort of patients with head and neck cancer treated with curative intensity-modulated radiation therapy.
    Head Neck. 2021 Feb 13. doi: 10.1002/hed.26638.
    PubMed     Abstract available


  264. BURGIN SJM, Spector ME, Pearson AT, Bellile E, et al
    Long-term neck and shoulder function among survivors of oropharyngeal squamous cell carcinoma treated with chemoradiation as assessed with the neck dissection impairment index.
    Head Neck. 2021 Feb 12. doi: 10.1002/hed.26636.
    PubMed     Abstract available


  265. POON DMC, Kam MKM, Johnson D, Mo F, et al
    Durability of the parotid-sparing effect of intensity-modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15-year follow-up of a randomized prospective study of IMRT versus two-dimensional radiotherapy.
    Head Neck. 2021 Feb 11. doi: 10.1002/hed.26634.
    PubMed     Abstract available


  266. ANG MK, Montoya JE, Tharavichitkul E, Lim C, et al
    A phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 5. doi: 10.1002/hed.26635.
    PubMed     Abstract available


  267. XIE G, Zhu A, Gu X
    Mitogen-activated protein kinase inhibition-induced modulation of epidermal growth factor receptor signaling in human head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 3. doi: 10.1002/hed.26633.
    PubMed     Abstract available


  268. ALVES LDB, Menezes ACS, Pereira DL, Santos MTC, et al
    Benefits of intraoral stents in patients with head and neck cancer undergoing radiotherapy: Systematic review.
    Head Neck. 2021 Feb 1. doi: 10.1002/hed.26620.
    PubMed     Abstract available


  269. HOLCOMB AJ, Richmon JD
    Transoral robotic salvage oropharyngectomy with submental artery island flap reconstruction.
    Head Neck. 2021;43:E13-E19.
    PubMed     Abstract available


  270. LAO WP, Lagabon KJ, Arom GA, Walker PC, et al
    Combined endoscopic and transoral resection of a high-staged juvenile nasopharyngeal angiofibroma: A pictorial essay.
    Head Neck. 2021;43:719-724.
    PubMed     Abstract available


  271. LE FLEM M, Santini L, Boulze C, Alshukry A, et al
    Reply to the Letter to the Editor regarding "Early oral hydration protects against pharyngocutaneous fistula after total laryngectomy or total pharyngolaryngectomy".
    Head Neck. 2021;43:718.
    PubMed    


  272. BINZ GHA, Soyka MB, Holzmann D, Meerwein CM, et al
    Need for long-term follow-up in sinonasal inverted papilloma: A Single-institution experience.
    Head Neck. 2021;43:630-638.
    PubMed     Abstract available


  273. EDAFE O
    Impact of early oral hydration on pharyngocutaneous fistula following total laryngectomy.
    Head Neck. 2021;43:716-717.
    PubMed    


  274. HUANG SH, de Almeida JR, Watson E, Glogauer M, et al
    Short-term and long-term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma.
    Head Neck. 2021;43:456-466.
    PubMed     Abstract available


  275. SU WW, Lee YH, Yen AM, Chen SL, et al
    Impact of treatment delay on survival of oral/oropharyngeal cancers: Results of a nationwide screening program.
    Head Neck. 2021;43:473-484.
    PubMed     Abstract available


  276. BOS P, van den Brekel MWM, Gouw ZAR, Al-Mamgani A, et al
    Clinical variables and magnetic resonance imaging-based radiomics predict human papillomavirus status of oropharyngeal cancer.
    Head Neck. 2021;43:485-495.
    PubMed     Abstract available


  277. HUANG TY, Lin YC, Tseng HY, Kim HY, et al
    Full percutaneous intraoperative neuromonitoring technique in remote thyroid surgery: Porcine model feasibility study.
    Head Neck. 2021;43:505-513.
    PubMed     Abstract available


    January 2021
  278. GISSI DB, Morandi L, Colella G, De Luca R, et al
    Clinical validation of 13-gene DNA methylation analysis in oral brushing samples for detection of oral carcinoma: An Italian multicenter study.
    Head Neck. 2021 Jan 28. doi: 10.1002/hed.26624.
    PubMed     Abstract available


  279. HOPKINS-ROSSABI T, Armeson KE, Zecker SG, Martin-Harris B, et al
    Respiratory-swallow coordination and swallowing impairment in head and neck cancer.
    Head Neck. 2021 Jan 25. doi: 10.1002/hed.26609.
    PubMed     Abstract available


  280. IQBAL MS, Kelly C, Kovarik J, McQueen A, et al
    Rapid recurrence in postoperative head and neck cancer: Underappreciated or overcalled problem?
    Head Neck. 2021 Jan 25. doi: 10.1002/hed.26615.
    PubMed    


  281. POLCE S, Gogineni E, Antone J, Ghaly M, et al
    Dental radiation dosimetric maps from intensity-modulated radiation therapy planning for head and neck cancers.
    Head Neck. 2021 Jan 15. doi: 10.1002/hed.26611.
    PubMed     Abstract available


  282. WEI ZG, Hu XL, He Y, Guan H, et al
    Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA.
    Head Neck. 2021 Jan 9. doi: 10.1002/hed.26608.
    PubMed     Abstract available


  283. MAYS AC, Yarlagadda B, Achim V, Jackson R, et al
    Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer.
    Head Neck. 2021 Jan 8. doi: 10.1002/hed.26601.
    PubMed     Abstract available


  284. INGARFIELD K, McMahon AD, Hurley K, Toms S, et al
    Inequality in survival of people with head and neck cancer: Head and Neck 5000 cohort study.
    Head Neck. 2021 Jan 8. doi: 10.1002/hed.26589.
    PubMed     Abstract available


  285. BROEMER L, Friedrich M, Wichmann G, Muller J, et al
    Exploratory study of functional and psychological factors associated with employment status in patients with head and neck cancer.
    Head Neck. 2021 Jan 1. doi: 10.1002/hed.26595.
    PubMed     Abstract available


  286. HAYDEN RE, Chang BA, Mullin DP, Patel AK, et al
    Bipedicled submental musculofascial "hammock" flap for salvage laryngectomy closure reinforcement.
    Head Neck. 2021;43:198-202.
    PubMed     Abstract available


  287. SHARBEL DD, Abkemeier M, Sullivan J, Zimmerman Z, et al
    Transcervical arterial ligation for prevention of postoperative hemorrhage in transoral oropharyngectomy: Systematic review and meta-analysis.
    Head Neck. 2021;43:334-344.
    PubMed     Abstract available


  288. MOORE EJ, Van Abel KM, Routman DM, Lohse CM, et al
    Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.
    Head Neck. 2021;43:229-237.
    PubMed     Abstract available


  289. CLARK CM, Newark AC, Fokar A, Maxwell JH, et al
    Aspirin use predicts prolonged survival in patients with oropharyngeal cancer: Nationwide Veterans Affairs database study.
    Head Neck. 2021;43:247-254.
    PubMed     Abstract available


  290. FUNG AS, Afzal AR, Banerjee R, Debenham B, et al
    A real-world comparison of cisplatin vs cetuximab used concurrently with radiation in the treatment of locally advanced oropharyngeal carcinoma.
    Head Neck. 2021;43:153-163.
    PubMed     Abstract available


  291. PANUGANTI BA, Stuart E, Weissbrod P
    Changes in treatment trends in the early glottic cancer population after the Affordable Care Act.
    Head Neck. 2021;43:137-144.
    PubMed     Abstract available


  292. CHWEYA CM, Low CM, Van Gompel JJ, Van Abel KM, et al
    Population-based analysis on the effect of nodal and distant metastases in sinonasal adenocarcinoma.
    Head Neck. 2021;43:128-136.
    PubMed     Abstract available


  293. ZEVALLOS JP, Kramer JR, Sandulache VC, Massa ST, et al
    National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System.
    Head Neck. 2021;43:108-115.
    PubMed     Abstract available


  294. THONG G, Brophy C, Sheahan P
    Use of intraoperative neural monitoring for prognostication of recovery of vocal mobility and reduction of permanent vocal paralysis after thyroidectomy.
    Head Neck. 2021;43:7-14.
    PubMed     Abstract available


    December 2020
  295. PANDIT PN, Patil RA, Palwe VS, Tambade SH, et al
    Patterns of blood pressure changes in patients with head and neck cancer receiving radiotherapy or chemo-radiotherapy at a tertiary cancer centre.
    Head Neck. 2020 Dec 29. doi: 10.1002/hed.26590.
    PubMed     Abstract available


  296. FANG R, Peng L, Chen L, Liao J, et al
    The survival benefit of lymph node dissection in resected T1-2, cN0 supraglottic cancer: A population-based propensity score matching analysis.
    Head Neck. 2020 Dec 29. doi: 10.1002/hed.26596.
    PubMed     Abstract available


  297. STARR N, Oyler DR, Schadler A, Aouad RK, et al
    Chronic opioid use after laryngeal cancer treatment.
    Head Neck. 2020 Dec 28. doi: 10.1002/hed.26591.
    PubMed     Abstract available


  298. RAO VUS, Subash A, R Bhargavi V, Sinha P, et al
    Selective embolization of lingual artery in transoral robotic surgery for the management of recurrent base of tongue carcinomas.
    Head Neck. 2020 Dec 24. doi: 10.1002/hed.26585.
    PubMed     Abstract available


  299. KISHIKAWA T, Suzuki M, Takemoto N, Fukusumi T, et al
    Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma.
    Head Neck. 2020 Dec 23. doi: 10.1002/hed.26583.
    PubMed     Abstract available


  300. GARCIA-ANAYA MJ, Ordonez R, Toledo MD, Correa RC, et al
    Importance of dose in palliative treatment for incurable head and neck cancer with radiotherapy.
    Head Neck. 2020 Dec 15. doi: 10.1002/hed.26555.
    PubMed     Abstract available


  301. ANDERSON EM, Luu M, Balzer BL, Scher KS, et al
    Variations in the association of grade with survival across the head and neck cancer landscape.
    Head Neck. 2020 Dec 10. doi: 10.1002/hed.26566.
    PubMed     Abstract available


  302. CHEN G, Jiang H, Jiang D, Wu Q, et al
    Pretreatment serum vitamin level predicts severity of radiation-induced oral mucositis in patients with nasopharyngeal carcinoma.
    Head Neck. 2020 Dec 10. doi: 10.1002/hed.26576.
    PubMed     Abstract available


  303. SANDLER ML, Xing MH, Levy JC, Chai RL, et al
    Metastatic thyroid carcinoma to the parapharyngeal and retropharyngeal spaces: Systematic review with seven newly reported cases describing an uncommon presentation of a common disease.
    Head Neck. 2020 Dec 9. doi: 10.1002/hed.26572.
    PubMed     Abstract available


  304. CARNABY GD, Chhabria K
    Preliminary development and validation of a measure of fear of swallowing and swallowing-related movement injury in head and neck cancer: Swallowing Kinesiophobia Scale.
    Head Neck. 2020 Dec 2. doi: 10.1002/hed.26573.
    PubMed     Abstract available


  305. WORKMAN AD, Soylu S, Kamani D, Nourmahnad A, et al
    Limitations of preoperative cytology for medullary thyroid cancer: Proposal for improved preoperative diagnosis for optimal initial medullary thyroid carcinoma specific surgery.
    Head Neck. 2020 Dec 2. doi: 10.1002/hed.26550.
    PubMed     Abstract available


    November 2020
  306. YI X, Chen W, Li C, Chen X, et al
    Circular RNA circ_0004507 contributes to laryngeal cancer progression and cisplatin resistance by sponging miR-873 to upregulate multidrug resistance 1 and multidrug resistance protein 1.
    Head Neck. 2020 Nov 28. doi: 10.1002/hed.26549.
    PubMed     Abstract available


  307. ZHANG Z, Xia F, Wang W, Jiang B, et al
    Ambulatory thyroidectomy is safe and beneficial in papillary thyroid carcinoma: Randomized controlled trial.
    Head Neck. 2020 Nov 28. doi: 10.1002/hed.26557.
    PubMed     Abstract available


  308. RITTER A, Badir S, Mansour M, Segal Z, et al
    Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients.
    Head Neck. 2020 Nov 27. doi: 10.1002/hed.26546.
    PubMed     Abstract available


  309. AKALI NR, Buggaveeti R, Sukumaran SV, Balasubramanian D, et al
    Prior chemoradiotherapy and pathological perineural invasion predict the survival outcomes of salvage surgery in head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 21. doi: 10.1002/hed.26547.
    PubMed     Abstract available


  310. JURICA JM, Rubio F, Hernandez DJ, Sandulache VC, et al
    Institutional financial toxicity of failure to adhere to treatment guidelines for head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 9. doi: 10.1002/hed.26539.
    PubMed     Abstract available


  311. CARRON J, Torricelli C, Silva JK, Queiroz GSR, et al
    microRNAs deregulation in head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 6. doi: 10.1002/hed.26533.
    PubMed     Abstract available


  312. ADEOYE J, Wan CCJ, Thomson P
    Mock clinical testing in the validation of fluid-phase biomarkers for head and neck carcinoma diagnosis: A Scoping review.
    Head Neck. 2020 Nov 5. doi: 10.1002/hed.26526.
    PubMed     Abstract available


  313. YUAN X, Zhang L, Huang Y, Liu D, et al
    Induction of interleukin-6 by irradiation and its role in epithelial mesenchymal transition and radioresistance of nasopharyngeal carcinoma cells.
    Head Neck. 2020 Nov 5. doi: 10.1002/hed.26531.
    PubMed     Abstract available


  314. HU CY, Wang WM, Chu XH, Ren ZH, et al
    Global, regional, and national burden of nasopharyngeal carcinoma from 1990 to 2017-Results from the Global Burden of Disease Study 2017.
    Head Neck. 2020;42:3243-3252.
    PubMed     Abstract available


    October 2020
  315. MOSES LE, Oliver JR, Rotsides JM, Shao Q, et al
    Nodal disease burden and outcome of medullary thyroid carcinoma.
    Head Neck. 2020 Oct 27. doi: 10.1002/hed.26511.
    PubMed     Abstract available


  316. CAVALIERI S, De Cecco L, Brakenhoff RH, Serafini MS, et al
    Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project.
    Head Neck. 2020 Oct 27. doi: 10.1002/hed.26515.
    PubMed     Abstract available


  317. MULDER FJ, Pierssens DDCG, Baijens LWJ, Kremer B, et al
    Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta-analysis on HPV, p16, and TP53.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26513.
    PubMed     Abstract available


  318. MARGALIT DN, Sacco AG, Cooper JS, Ridge JA, et al
    Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26490.
    PubMed     Abstract available


  319. LIU W, Qdaisat A, Zhou S, Fuller CD, et al
    Hypomagnesemia and incidence of osteoradionecrosis in patients with head and neck cancers.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26510.
    PubMed     Abstract available


  320. KONO M, Wakisaka R, Kumai T, Hayashi R, et al
    Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy.
    Head Neck. 2020 Oct 5. doi: 10.1002/hed.26502.
    PubMed     Abstract available


  321. GADKAREE SK, McCarty JC, Feng AL, Siu JM, et al
    Role of physician density in predicting stage and survival for head and neck squamous cell carcinoma.
    Head Neck. 2020 Oct 4. doi: 10.1002/hed.26495.
    PubMed     Abstract available


  322. WANG Z, Yuan H, Huang J, Hu D, et al
    Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
    Head Neck. 2020 Oct 3. doi: 10.1002/hed.26474.
    PubMed     Abstract available


  323. OKANO W, Hayashi R, Matsuura K, Shinozaki T, et al
    Extent of salvage neck dissection following chemoradiation for locally advanced head and neck cancer.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26494.
    PubMed     Abstract available


  324. KARATAS OF, Capik O, Barlak N, Aydin Karatas E, et al
    Comprehensive in silico analysis for identification of novel candidate target genes, including DHX36, OPA1, and SENP2, located on chromosome 3q in head and neck cancers.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26493.
    PubMed     Abstract available


  325. JEANS C, Ward EC, Brown B, Vertigan AE, et al
    Association between external and internal lymphedema and chronic dysphagia following head and neck cancer treatment.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26484.
    PubMed     Abstract available


  326. SYKES KJ, Morrow E, Smith JB, Holcomb AJ, et al
    What is the hold up?-Mixed-methods analysis of postoperative radiotherapy delay in head and neck cancer.
    Head Neck. 2020;42:2948-2957.
    PubMed     Abstract available


    September 2020
  327. SVAJDOVA M, Dubinsky P, Kazda T
    Radical external beam re-irradiation in the treatment of recurrent head and neck cancer: Critical review.
    Head Neck. 2020 Sep 30. doi: 10.1002/hed.26485.
    PubMed     Abstract available


  328. BRENNAN MT, Treister NS, Sollecito TP, Schmidt BL, et al
    Epidemiologic factors in patients with advanced head and neck cancer treated with radiation therapy.
    Head Neck. 2020 Sep 29. doi: 10.1002/hed.26468.
    PubMed     Abstract available


  329. LEE DY, Abraham J, Ross E, Ridge JA, et al
    Rapid recurrence in head and neck cancer: Underappreciated problem with poor outcome.
    Head Neck. 2020 Sep 29. doi: 10.1002/hed.26479.
    PubMed     Abstract available


  330. LIU YP, Wang SL, Zou X, You R, et al
    Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence.
    Head Neck. 2020 Sep 28. doi: 10.1002/hed.26459.
    PubMed     Abstract available


  331. MHASKAR R, Caputo MP, Mifsud MJ
    Reply to Letter to the Editor regarding "Diabetes mellitus in major head and neck cancer surgery: Systematic review and meta-analysis".
    Head Neck. 2020 Sep 23. doi: 10.1002/hed.26446.
    PubMed    


  332. HUANG GJ, Kong XY
    Diabetes mellitus in major head and neck cancer surgery.
    Head Neck. 2020 Sep 23. doi: 10.1002/hed.26451.
    PubMed    


  333. KRIPLANI A, Lavery JA, Mishra A, Korenstein D, et al
    Trends in chronic opioid therapy among survivors of head and neck cancer.
    Head Neck. 2020 Sep 22. doi: 10.1002/hed.26478.
    PubMed     Abstract available


  334. LIAO AH, Lin WT, Chen HK, Shih CP, et al
    Synergistic effects of combined treatment with ultrasound-mediated cisplatin-loaded microbubbles and atorvastatin on head and neck cancer.
    Head Neck. 2020 Sep 21. doi: 10.1002/hed.26445.
    PubMed     Abstract available


  335. LUO Y, Ma J, Liu F, Guo J, et al
    Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma.
    Head Neck. 2020 Sep 18. doi: 10.1002/hed.26441.
    PubMed     Abstract available


    July 2020
  336. HOLMES BJ, von Eyben R, Attardi LD, Kong CS, et al
    Pilot study of loss of the p53/p63 target gene PERP at the surgical margin as a potential predictor of local relapse in head and neck squamous cell carcinoma.
    Head Neck. 2020 Jul 7. doi: 10.1002/hed.26358.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Otorhinolaryngology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: